MDB Capital (MDBH) Q3 2026 Earnings Call Transcript

MDB Capital executives outlined plans to fund subsidiaries separately and distribute assets to shareholders as businesses reach commercial milestones. The company reported $4.2 million in fee income for the first nine months and $8.3 million in operating cash at quarter-end. Paulex Bio raised $19 million, with its first patient dosing for a diabetes treatment now expected in December 2026.
Ad
0Like0Dislike0Comments0Shares






Comments 0
No comments yet. Be the first to share your view in the app.
Join the discussion: comments and votes are in the free Beloud app.